Innovent Biologics Inc (6IB) — Free Cash Flow Generation Index
Innovent Biologics Inc (6IB) has a Free Cash Flow Generation Index of 1.97x as of December 2020. Free cash flow of €429.10 Million represents 2% of operating cash flow (€217.96 Million). Read Innovent Biologics Inc debt and liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Innovent Biologics Inc Free Cash Flow Generation Index (2023–2025)
Historical FCF Generation Index trend for Innovent Biologics Inc across 3 annual periods. Explore Innovent Biologics Inc capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Innovent Biologics Inc (2023–2025)
Year-by-year Free Cash Flow Generation Index for Innovent Biologics Inc. For the full company profile including market capitalisation, see Innovent Biologics Inc (6IB) total market value.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.93x | €9.32 Billion | €10.00 Billion | €683.27 Million | ▲ +386.6% |
| 2024 | -0.33x | €-418.39 Million | €1.29 Billion | €1.71 Billion | ▲ +96.1% |
| 2023 | -8.36x | €-1.24 Billion | €147.81 Million | €1.38 Billion | — |